Published in PLoS One on July 05, 2013
miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α. J Clin Endocrinol Metab (2014) 0.91
MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2. Oncotarget (2016) 0.89
CKS2 in human cancers: Clinical roles and current perspectives (Review). Mol Clin Oncol (2015) 0.79
Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role. Onco Targets Ther (2016) 0.79
Cancer stem cells as a potential therapeutic target in thyroid carcinoma. Oncol Lett (2016) 0.77
MiRNAs in Astrocyte-Derived Exosomes as Possible Mediators of Neuronal Plasticity. J Exp Neurosci (2016) 0.75
Up-regulated CKS2 promotes tumor progression and predicts a poor prognosis in human colorectal cancer. Am J Cancer Res (2015) 0.75
Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc (2008) 62.52
Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet (2004) 12.97
The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A (2005) 8.60
MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med (2009) 6.13
Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1. Proc Natl Acad Sci U S A (2006) 5.16
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev (2009) 4.15
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene (2007) 3.29
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood (2008) 3.03
MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res (2011) 3.03
MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer (2009) 2.57
The fission yeast cell cycle control gene cdc2: isolation of a sequence suc1 that suppresses cdc2 mutant function. Mol Gen Genet (1986) 2.46
Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Sci (2008) 2.01
Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol (2007) 1.89
Human cDNAs encoding homologs of the small p34Cdc28/Cdc2-associated protein of Saccharomyces cerevisiae and Schizosaccharomyces pombe. Genes Dev (1990) 1.83
From Cdc2 to Cdk1: when did the cell cycle kinase join its cyclin partner? J Cell Sci (2002) 1.71
MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin. Gastroenterology (2012) 1.48
Cyclin-dependent kinase-associated proteins Cks1 and Cks2 are essential during early embryogenesis and for cell cycle progression in somatic cells. Mol Cell Biol (2008) 1.28
Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients. Genes Chromosomes Cancer (2012) 1.26
Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas. Endocr Relat Cancer (2010) 1.16
Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death. Int J Cancer (2008) 1.15
MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells. Cancer Genet (2012) 1.03
Papillary thyroid carcinoma: differential diagnosis and prognostic values of its different variants: review of the literature. ISRN Oncol (2011) 1.02
Proteomic profiling of thyroid papillary carcinoma. J Thyroid Res (2012) 0.80
A robust DNA mechanical device controlled by hybridization topology. Nature (2002) 4.45
Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther (2010) 1.90
Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9. Diabetes (2005) 1.70
Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice. Diabetes (2009) 1.65
Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations. Mol Cell Biol (2007) 1.62
pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2. Mol Cell (2007) 1.47
Genetic associations with coronary heart disease: meta-analyses of 12 candidate genetic variants. Gene (2013) 1.45
A meta-analysis of plate fixation versus intramedullary nailing for humeral shaft fractures. J Orthop Sci (2013) 1.43
MiR-223 suppresses cell proliferation by targeting IGF-1R. PLoS One (2011) 1.41
(E)-1-{4-[Bis(4-meth-oxy-phen-yl)meth-yl]piperazin-1-yl}-3-(3,4-dieth-oxy-phen-yl)prop-2-en-1-one ethanol disolvate. Acta Crystallogr Sect E Struct Rep Online (2012) 1.39
Double cohesion in structural DNA nanotechnology. Org Biomol Chem (2006) 1.26
Anterograde trafficking of G protein-coupled receptors: function of the C-terminal F(X)6LL motif in export from the endoplasmic reticulum. Mol Pharmacol (2008) 1.25
Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia. J Clin Invest (2014) 1.24
Lipid raft distribution of CD4 depends on its palmitoylation and association with Lck, and evidence for CD4-induced lipid raft aggregation as an additional mechanism to enhance CD3 signaling. J Immunol (2003) 1.23
Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes. J Med Chem (2014) 1.22
Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer. Cancer (2014) 1.20
MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP(L). Cancer Res (2007) 1.20
(E)-1-{4-[Bis(4-bromo-phen-yl)meth-yl]piperazin-1-yl}-3-(4-eth-oxy-3-meth-oxy-phen-yl)prop-2-en-1-one. Acta Crystallogr Sect E Struct Rep Online (2011) 1.19
The power and the promise of liver cancer stem cell markers. Stem Cells Dev (2011) 1.18
Human organic anion-transporting polypeptide OATP-A (SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the vectorial transport of Saquinavir in Hep G2 cells. Mol Pharm (2004) 1.18
The genus Cordyceps: a chemical and pharmacological review. J Pharm Pharmacol (2012) 1.16
Retinoblastoma tumor suppressor targets dNTP metabolism to regulate DNA replication. J Biol Chem (2002) 1.16
The potential role of ubiquitin c-terminal hydrolases in oncogenesis. Biochim Biophys Acta (2010) 1.15
Role of the microenvironment in hepatocellular carcinoma development and progression. Cancer Treat Rev (2011) 1.13
(E)-1-{4-[Bis(4-fluoro-phen-yl)meth-yl]piperazin-1-yl}-3-(4-eth-oxy-phen-yl)prop-2-en-1-one. Acta Crystallogr Sect E Struct Rep Online (2011) 1.11
MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancer. Cell Physiol Biochem (2013) 1.11
The diversity and anti-microbial activity of endophytic actinomycetes isolated from medicinal plants in Panxi plateau, China. Curr Microbiol (2010) 1.10
HIV Nef-mediated CD4 down-regulation is adaptor protein complex 2 dependent. J Immunol (2005) 1.09
Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females. PLoS One (2013) 1.09
A single conserved leucine residue on the first intracellular loop regulates ER export of G protein-coupled receptors. Traffic (2009) 1.07
(E)-1-{4-[Bis(4-bromo-phen-yl)meth-yl]piperazin-1-yl}-3-(4-bromo-phen-yl)prop-2-en-1-one. Acta Crystallogr Sect E Struct Rep Online (2011) 1.07
Exposure to 1800 MHz radiofrequency radiation induces oxidative damage to mitochondrial DNA in primary cultured neurons. Brain Res (2009) 1.06
Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model. Cancer Lett (2006) 1.05
miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes. J Cancer Res Clin Oncol (2014) 1.05
Discrete signaling pathways participate in RB-dependent responses to chemotherapeutic agents. Oncogene (2004) 1.05
Rab8 interacts with distinct motifs in alpha2B- and beta2-adrenergic receptors and differentially modulates their transport. J Biol Chem (2010) 1.04
ADP-ribosylation factors modulate the cell surface transport of G protein-coupled receptors. J Pharmacol Exp Ther (2010) 1.01
In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library. Biochem Biophys Res Commun (2006) 1.00
Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis. Cell Res (2012) 1.00
Discovery of a highly potent, selective, and bioavailable soluble epoxide hydrolase inhibitor with excellent ex vivo target engagement. J Med Chem (2009) 0.99
Prevalence of human papillomavirus infection in Guangdong Province, China: a population-based survey of 78,355 women. Sex Transm Dis (2014) 0.99
Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs. Adv Drug Deliv Rev (2009) 0.99
Involvement of FLIP in 2-methoxyestradiol-induced tumor regression in transgenic adenocarcinoma of mouse prostate model. Clin Cancer Res (2009) 0.97
Quantification of Adventitial Vasa Vasorum Vascularization in Double-injury Restenotic Arteries. Chin Med J (Engl) (2015) 0.96
Long-term antiepileptic drug administration during early life inhibits hippocampal neurogenesis in the developing brain. J Neurosci Res (2009) 0.96
Expression and clinical significance of UCH37 in human esophageal squamous cell carcinoma. Dig Dis Sci (2012) 0.96
RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis. Carcinogenesis (2012) 0.95
MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin. Biochem Biophys Res Commun (2012) 0.95
MicroRNA-34a suppresses cell proliferation by targeting LMTK3 in human breast cancer mcf-7 cell line. DNA Cell Biol (2013) 0.95
dUev1a modulates TNF-JNK mediated tumor progression and cell death in Drosophila. Dev Biol (2013) 0.94
MiR-145 regulates PAK4 via the MAPK pathway and exhibits an antitumor effect in human colon cells. Biochem Biophys Res Commun (2012) 0.94
Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitors. Bioorg Med Chem Lett (2009) 0.94
MicroRNA-326 functions as a tumor suppressor in glioma by targeting the Nin one binding protein (NOB1). PLoS One (2013) 0.93
Double-stranded DNA homology produces a physical signature. Proc Natl Acad Sci U S A (2010) 0.93
Regulation of integrin αV subunit expression by sulfatide in hepatocellular carcinoma cells. J Lipid Res (2013) 0.92
Association between PON1 activity and coronary heart disease risk: a meta-analysis based on 43 studies. Mol Genet Metab (2011) 0.92
Three-stage enzymatic hydrolysis of steam-exploded corn stover at high substrate concentration. Bioresour Technol (2010) 0.92
Meta-analyses of KIF6 Trp719Arg in coronary heart disease and statin therapeutic effect. PLoS One (2012) 0.92
Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3. PLoS One (2013) 0.92
An association study between genetic polymorphisms related to lipoprotein-associated phospholipase A(2) and coronary heart disease. Exp Ther Med (2013) 0.92
Green tea epigallocatechin-3-gallate (EGCG) promotes neural progenitor cell proliferation and sonic hedgehog pathway activation during adult hippocampal neurogenesis. Mol Nutr Food Res (2012) 0.92
Increased expression of microRNA-221 inhibits PAK1 in endothelial progenitor cells and impairs its function via c-Raf/MEK/ERK pathway. Biochem Biophys Res Commun (2013) 0.91
Regulatory T cell: a protection for tumour cells. J Cell Mol Med (2012) 0.91
Upregulated microRNA-155 expression in peripheral blood mononuclear cells and fibroblast-like synoviocytes in rheumatoid arthritis. Clin Dev Immunol (2013) 0.91
Quantitative assessment of the effect of ABCA1 gene polymorphism on the risk of Alzheimer's disease. Mol Biol Rep (2012) 0.91
MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3. Cell Physiol Biochem (2015) 0.91
Diversity and infectivity of arbuscular mycorrhizal fungi in agricultural soils of the Sichuan Province of mainland China. Mycorrhiza (2008) 0.91
HPV genotypes and associated cervical cytological abnormalities in women from the Pearl River Delta region of Guangdong province, China: a cross-sectional study. BMC Infect Dis (2014) 0.91
Meta-analysis of the effect of HHEX gene polymorphism on the risk of type 2 diabetes. Mutagenesis (2010) 0.90
Population pharmacokinetics and exposure-response relationship of enfuvirtide in treatment-experienced human immunodeficiency virus type 1-infected patients. Clin Pharmacol Ther (2005) 0.90
Ligustrazine attenuates oxidative stress-induced activation of hepatic stellate cells by interrupting platelet-derived growth factor-β receptor-mediated ERK and p38 pathways. Toxicol Appl Pharmacol (2012) 0.90
microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis. Oncol Rep (2013) 0.90
The Fas/Fas ligand death receptor pathway contributes to phenylalanine-induced apoptosis in cortical neurons. PLoS One (2013) 0.90
Vascular endothelial growth factor -634G/C and vascular endothelial growth factor -2578C/A polymorphisms and lung cancer risk: a case-control study and meta-analysis. Tumour Biol (2013) 0.90
Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells. J Cell Mol Med (2014) 0.90
Beta-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice. Hepatogastroenterology (2012) 0.89
DLC1-dependent parathyroid hormone-like hormone inhibition suppresses breast cancer bone metastasis. J Clin Invest (2014) 0.89
Low expression of lncRNA-HMlincRNA717 in human gastric cancer and its clinical significances. Tumour Biol (2014) 0.89
Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors. Bioorg Med Chem Lett (2009) 0.89
Lysine 144, a ubiquitin attachment site in HIV-1 Nef, is required for Nef-mediated CD4 down-regulation. J Immunol (2008) 0.89
Three-stage hydrolysis to enhance enzymatic saccharification of steam-exploded corn stover. Bioresour Technol (2009) 0.89
Tetramethylpyrazine reduces glucose and insulin-induced activation of hepatic stellate cells by inhibiting insulin receptor-mediated PI3K/AKT and ERK pathways. Mol Cell Endocrinol (2013) 0.88
Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer. Breast Cancer Res Treat (2010) 0.88
Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling. J Clin Endocrinol Metab (2013) 0.87
Expression of the c-Met proto-oncogene and Integrin α5β1 in human gastric cardia adenocarcinoma. Biosci Biotechnol Biochem (2012) 0.87